Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Methotrexate × Gastrointestinal × Clear all

Phase

Status

Terminated 2 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 194 Lymphoid 190 Myeloid 48 Sarcoma 34 Breast 34 Plasma cell 20 Classical hematology 20 CNS 16 Genitourinary 14 Dermatologic 12 Head & Neck 9 Gynecologic 4 Tumor-Agnostic 3 Thoracic 3 Other solid neoplasm 2 Other neoplasm 2 Other 2 Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Fluorouracil 513 Oxaliplatin 477 Gemcitabine 419 Capecitabine 377 Leucovorin 353 Irinotecan 324 Cisplatin 273 Bevacizumab 270 Radiotherapy 209 Cetuximab 177 Sorafenib 141 Docetaxel 129 pembrolizumab 120 Paclitaxel 114 Nivolumab 100 Folfox protocol 87 Albumin-Bound Paclitaxel 85 Erlotinib Hydrochloride 84 130-nm albumin-bound paclitaxel 82 Panitumumab 78 Surgical Procedures, Operative 71 S 1 (combination) 71 Drug Therapy 71 regorafenib 70 Radiation 59 Neoadjuvant Therapy 56 Colonoscopy 53 Carboplatin 53 Radiosurgery 52 Surveys and Questionnaires 51

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02280694 2020-02-12

LDMchemoCRC

HaEmek Medical Center, Israel

Phase 2 Completed

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡